Research programme: Anticancer small molecules - 858 Therapeutics
Alternative Names: Small molecule inihibitors - 858 TherapeuticsLatest Information Update: 16 Jan 2025
Price :
$50 *
At a glance
- Originator 858 Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cancer